← Back to Search

High-Intensity vs Moderate-Intensity Gait Training for Multiple Sclerosis

N/A
Waitlist Available
Research Sponsored by City University of New York
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 10 minutes
Awards & highlights
No Placebo-Only Group

Summary

This trial will compare the effects of high intensity interval gait training (HIIGT) to traditional moderate intensity continuous gait training (MICGT) in people with MS who have difficulty walking.

Who is the study for?
This trial is for English-speaking adults over 18 with Multiple Sclerosis who can walk for 6 minutes, even if they need a device to help them. It's not open to those with heart/lung problems, recent MS flare-ups, or other neurological/orthopedic conditions.
What is being tested?
The study compares two types of walking exercises: High Intensity Interval Gait Training (fast walking with rest breaks) and Moderate Intensity Continuous Gait Training (steady slower walking), to see which is better for improving walking in people with MS.
What are the potential side effects?
Potential side effects may include muscle soreness, fatigue from exercise, and an increased risk of falls during training sessions due to the physical nature of the interventions.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~10 minutes
This trial's timeline: 3 weeks for screening, Varies for treatment, and 10 minutes for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
6 minute walk test
Secondary study objectives
Finctional gait assessment

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: ExperimentalExperimental Treatment1 Intervention
High intensity interval gait training
Group II: ControlActive Control1 Intervention
Moderate intesnity continuous gait training

Find a Location

Who is running the clinical trial?

City University of New YorkLead Sponsor
17 Previous Clinical Trials
5,746 Total Patients Enrolled

Media Library

High Intensity Interval gait training Clinical Trial Eligibility Overview. Trial Name: NCT05529498 — N/A
Multiple Sclerosis Research Study Groups: Control, Experimental
Multiple Sclerosis Clinical Trial 2023: High Intensity Interval gait training Highlights & Side Effects. Trial Name: NCT05529498 — N/A
High Intensity Interval gait training 2023 Treatment Timeline for Medical Study. Trial Name: NCT05529498 — N/A
Multiple Sclerosis Patient Testimony for trial: Trial Name: NCT05529498 — N/A
~9 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top